Combinatorial library strategies for synthesis of cationic lipid-like nanoparticles and their potential medical applications.

The past two decades have witnessed the high efficiency and efficacy of cationic lipids and liposomal formations for drug delivery. The tedious synthesis of conventional lipids and the inefficiency in studying structure-activity relationships, however, have hindered the clinical translation of lipid nanoparticle delivery systems. Combinatorial synthesis of lipid-like nanoparticles ('lipidoids') has recently emerged as an approach to accelerate the development of these delivery platforms. Utilizing a high-throughput screening strategy, the libraries of lipidoids are sorted and prime candidates for the delivery in the intended application can be identified and optimized for the next generation. In this review, we outline methods used for combinatorial lipidoid synthesis, the application of high-throughput screening, and the current medical applications of candidate lipidoids.

[1]  R. Townley,et al.  Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody. , 2004, Pediatrics.

[2]  Nathan F. Bouxsein,et al.  Synthesis and characterization of degradable multivalent cationic lipids with disulfide-bond spacers for gene delivery. , 2011, Biochimica et biophysica acta.

[3]  Andrew D. Miller,et al.  What Role Can Chemistry Play in Cationic Liposome-Based Gene Therapy Research Today? , 2005, Advances in genetics.

[4]  P. Levkin,et al.  Combinatorial synthesis and high-throughput screening of alkyl amines for nonviral gene delivery. , 2013, Bioconjugate chemistry.

[5]  Shubiao Zhang,et al.  Non-viral vectors for the mediation of RNAi. , 2012, Bioorganic chemistry.

[6]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[7]  P. Wipf,et al.  Combinatorial chemistry and contemporary pharmacology. , 2000, The Journal of pharmacology and experimental therapeutics.

[8]  S. Balu-Iyer,et al.  Delivery of therapeutic proteins. , 2010, Journal of pharmaceutical sciences.

[9]  Bing Wang,et al.  Novel gemini cationic lipids with carbamate groups for gene delivery. , 2014, Journal of materials chemistry. B.

[10]  L. Palmer,et al.  Stabilized plasmid-lipid particles: construction and characterization , 1999, Gene Therapy.

[11]  D. Hoekstra,et al.  Cationic lipids, lipoplexes and intracellular delivery of genes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Ruilong Sheng,et al.  'Click' synthesized sterol-based cationic lipids as gene carriers, and the effect of skeletons and headgroups on gene delivery. , 2013, Bioorganic & medicinal chemistry.

[13]  Michael S. Goldberg,et al.  Drug Delivery–mediated Control of RNA Immunostimulation , 2009, Molecular Therapy.

[14]  Gang Zheng,et al.  Lipid-based nanoparticles in the systemic delivery of siRNA. , 2014, Nanomedicine.

[15]  Yong Ren,et al.  Recent advances in nanoparticle-mediated siRNA delivery. , 2014, Annual review of biomedical engineering.

[16]  Annamaria Lilienkampf,et al.  Solid-phase synthesis of arginine-based double-tailed cationic lipopeptides: potent nucleic acid carriers. , 2011, Chemical communications.

[17]  Daniel G. Anderson,et al.  Combinatorial approach to determine functional group effects on lipidoid-mediated siRNA delivery. , 2010, Bioconjugate chemistry.

[18]  Robert Langer,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[19]  R. Langer,et al.  Lipid‐based nanotherapeutics for siRNA delivery , 2010, Journal of internal medicine.

[20]  P. Felgner,et al.  Cationic liposome-mediated transfection , 1989, Nature.

[21]  K. W. Jung,et al.  Cesium effect: high chemoselectivity in direct N-alkylation of amines. , 2002, The Journal of organic chemistry.

[22]  Gunter Meister,et al.  Small RNAs derived from longer non-coding RNAs. , 2011, Biochimie.

[23]  G. Zuber,et al.  A cationic phospholipid-detergent conjugate as a new efficient carrier for siRNA delivery. , 2012, Chemistry.

[24]  Daniel G. Anderson,et al.  Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  Michael S. Goldberg,et al.  Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery , 2012, Proceedings of the National Academy of Sciences.

[26]  Robert Langer,et al.  Lipid‐Like Nanoparticles for Small Interfering RNA Delivery to Endothelial Cells , 2009, Advanced functional materials.

[27]  M. G. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions , 2001 .

[28]  M. Foldvari,et al.  Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies. , 2010, Nanomedicine.

[29]  A. Chaudhuri,et al.  Cationic liposomes as non‐viral carriers of gene medicines: Resolved issues, open questions, and future promises , 2007, Medicinal research reviews.

[30]  S. Simões,et al.  Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. , 2001, Advanced drug delivery reviews.

[31]  David E. Golan,et al.  Protein therapeutics: a summary and pharmacological classification , 2008, Nature Reviews Drug Discovery.

[32]  S. Futaki,et al.  Dynamic amphiphile libraries to screen for the "fragrant" delivery of siRNA into HeLa cells and human primary fibroblasts. , 2013, Journal of the American Chemical Society.

[33]  Peixuan Guo,et al.  Stable RNA nanoparticles as potential new generation drugs for cancer therapy. , 2014, Advanced drug delivery reviews.

[34]  W. Radchatawedchakoon,et al.  Solid phase synthesis of novel asymmetric hydrophilic head cholesterol-based cationic lipids with potential DNA delivery. , 2010, Bioorganic & medicinal chemistry.

[35]  Robert Langer,et al.  Combinatorial library of lipidoids for in vitro DNA delivery. , 2012, Bioconjugate chemistry.

[36]  Robert Langer,et al.  Small RNA combination therapy for lung cancer , 2014, Proceedings of the National Academy of Sciences.

[37]  P. Levkin,et al.  A biomimetic lipid library for gene delivery through thiol-yne click chemistry. , 2012, Biomaterials.

[38]  Qiaobing Xu,et al.  A combinatorial library of unsaturated lipidoids for efficient intracellular gene delivery. , 2012, ACS synthetic biology.

[39]  Y. Namiki,et al.  Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. , 2011, Accounts of chemical research.

[40]  Sandra Ristori,et al.  Bioreducible Liposomes for Gene Delivery: From the Formulation to the Mechanism of Action , 2010, PloS one.

[41]  Michael S. Goldberg,et al.  Development of lipidoid-siRNA formulations for systemic delivery to the liver. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  Robert Langer,et al.  Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery , 2013, Proceedings of the National Academy of Sciences.

[43]  F. Szoka,et al.  Lipid-based Nanoparticles for Nucleic Acid Delivery , 2007, Pharmaceutical Research.

[44]  Ernst Wagner,et al.  Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Farnaz Niroui,et al.  In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery. , 2012, ACS nano.

[46]  Y. Anraku,et al.  Smart multilayered assembly for biocompatible siRNA delivery featuring dissolvable silica, endosome-disrupting polycation, and detachable PEG. , 2012, ACS nano.

[47]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[48]  Michael S. Goldberg Lipidoids: A Combinatorial Approach to siRNA Delivery , 2013 .

[49]  Leaf Huang,et al.  Lipid-based vectors for siRNA delivery , 2012, Journal of drug targeting.

[50]  I. Georgakoudi,et al.  Enhanced Intracellular siRNA Delivery using Bioreducible Lipid‐Like Nanoparticles , 2014, Advanced healthcare materials.

[51]  U. Massing,et al.  Combinatorial Synthesis of New Cationic Lipids and High‐Throughput Screening of Their Transfection Properties , 2002, Chembiochem : a European journal of chemical biology.

[52]  Robert Langer,et al.  Degradable Lipid Nanoparticles with Predictable In Vivo siRNA Delivery Activity , 2014, Nature Communications.

[53]  Qiaobing Xu,et al.  DOPE facilitates quaternized lipidoids (QLDs) for in vitro DNA delivery. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[54]  I. Verma,et al.  Cationic liposome-mediated RNA transfection. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Kumar,et al.  Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. , 1994, The Journal of biological chemistry.

[56]  Joo Yeon Park,et al.  Application of cationic liposomes for delivery of nucleic acids , 2013 .

[57]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[58]  Kathryn A. Whitehead,et al.  Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.

[59]  Michael Greenberg,et al.  Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes , 2004, Nature Reviews Drug Discovery.

[60]  J. Behr,et al.  Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Daniel G. Anderson,et al.  Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.

[62]  T. Elliott,et al.  Solid-phase synthesis of 89 polyamine-based cationic lipids for DNA delivery to mammalian cells. , 2004, Chemistry.

[63]  Lyndsay N Harris,et al.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  Benjamin C. Tang,et al.  Lipid‐Like Nanomaterials for Simultaneous Gene Expression and Silencing In Vivo , 2014, Advanced healthcare materials.

[65]  Kwangmeyung Kim,et al.  Tumor‐Targeting Multifunctional Nanoparticles for siRNA Delivery: Recent Advances in Cancer Therapy , 2014, Advanced healthcare materials.

[66]  Qiaobing Xu,et al.  Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy. , 2014, Angewandte Chemie.

[67]  B. Merrifield,et al.  Concept and early development of solid-phase peptide synthesis. , 1997, Methods in enzymology.

[68]  Joel A Swanson,et al.  Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. , 2003, Advanced drug delivery reviews.

[69]  D. Nair,et al.  The Thiol‐Michael Addition Click Reaction: A Powerful and Widely Used Tool in Materials Chemistry , 2014 .